Carregant...
Myeloid‐derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
Myeloid‐derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that accumulate during pathologic conditions, such as cancer. Patients diagnosed with advanced metastatic cancers have an average survival of 12–24 mo, a survival time that hasn't changed significa...
Guardat en:
| Publicat a: | J Leukoc Biol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Society for Leukocyte Biology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608049/ https://ncbi.nlm.nih.gov/pubmed/28546500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.5VMR1116-458RRR |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|